Selloff or Market Correction? Either Way, Here's What to Do NextSee Overvalued Stocks

Schumer sees next big U.S. COVID-19 relief bill passing in 4-6 weeks

Published 01/25/2021, 10:19 AM
Updated 01/25/2021, 04:25 PM
© Reuters. FILE PHOTO: Los Angeles Regional Food Bank drive-thru distribution in West Covina

By David Morgan

WASHINGTON (Reuters) - The U.S. Senate is aiming to approve some coronavirus relief before former President Donald Trump's impeachment trial begins in early February, but Democratic Majority Leader Chuck Schumer warned a comprehensive deal may be four to six weeks away.

President Joe Biden is pushing for a sweeping $1.9 trillion response bill, but after Congress approved $4 trillion in spending to address the pandemic, including $900 billion last month, some prominent Republicans have pushed back on the idea of passing so large a bill so quickly.

"We'll try to get that passed in the next month, month and a half," said Schumer, whose Democrats control the 50-50 Senate thanks only to Vice President Kamala Harris' tie-breaking vote.

"Will it be easy in the Senate? No," he told New York City public transportation advocates. "But it'll be a lot easier because I can determine what's put on the floor, not (Senate Minority Leader Mitch) McConnell."

Schumer and McConnell - who served as majority leader for the last six years - are posturing for advantage in the divided chamber and so far have failed to agree on a power-sharing arrangement to determine how the Senate will run day-to-day operations for the next two years.

Biden has made addressing the pandemic, which has killed more than 418,000 Americans and is infecting more than 170,000 people in the United States each day, a primary initial thrust of his administration.

Earlier on Monday, Senator Angus King said the Senate was planning to consider a bill within the next two weeks, while it also moves to confirm Biden's Cabinet ahead of the Trump trial's start during the week of Feb. 8.

"We're going to try to do something between now and the time of the impeachment trial beginning," King told National Public Radio.

King and Republican Senator Bill Cassidy, who both participated in a call about COVID-19 relief with Biden administration officials on Sunday, said there is broad agreement about the need to move forward on vaccinations.

"We can all agree: we need to have money out there for vaccines," Cassidy told Fox News on Monday. "And testing, we can accept that."

King said there was a general consensus on Sunday's call to do "whatever we have to do to speed up the vaccination process. I don't think there's going to be any debate about that."

He added that the group on Sunday's call would speak again on Monday or Tuesday.

The narrow margins of Democratic control in the House of Representatives and Senate mean that any legislation would need bipartisan support to become law.

In addition to the size of Biden's plan, Republicans and some Democrats are concerned about a proposal to send $1,400 stimulus checks to most Americans, even some with fairly high incomes.

© Reuters. FILE PHOTO: Los Angeles Regional Food Bank drive-thru distribution in West Covina

House committees are expected to work on legislation this week, with the aim of being ready to put a bill on the House floor during the first week of February.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.